These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11598453)

  • 1. Genetic aberrations of NAT2 and chromosome 8: their association with progression in transitional cell carcinoma of the urinary bladder.
    Watters AD; Stacey MW; Going JJ; Grigor KM; Cooke TG; Sim E; Bartlett JM
    Urol Int; 2001; 67(3):235-9. PubMed ID: 11598453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression to detrusor-muscle invasion in bladder carcinoma is associated with polysomy of chromosomes 1 and 8 in recurrent pTa/pT1 tumours.
    Watters AD; Going JJ; Grigor KM; Bartlett JM
    Eur J Cancer; 2002 Aug; 38(12):1593-9. PubMed ID: 12142047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic aberrations of c-myc and CCND1 in the development of invasive bladder cancer.
    Watters AD; Latif Z; Forsyth A; Dunn I; Underwood MA; Grigor KM; Bartlett JM
    Br J Cancer; 2002 Sep; 87(6):654-8. PubMed ID: 12237776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genes for human arylamine N-acetyltransferases in relation to loss of the short arm of chromosome 8 in bladder cancer.
    Thygesen P; Risch A; Stacey M; Fakis G; Giannoulis F; Takle L; Knowles M; Sim E
    Pharmacogenetics; 1999 Feb; 9(1):1-8. PubMed ID: 10208636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arylamine N-acetyltransferase type 2 (NAT2), chromosome 8 aneuploidy, and identification of a novel NAT1 cosmid clone: an investigation in bladder cancer by interphase FISH.
    Stacey M; Matas N; Drake M; Payton M; Fakis G; Greenland J; Sim E
    Genes Chromosomes Cancer; 1999 Aug; 25(4):376-83. PubMed ID: 10398432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladder.
    Krüger S; Mess F; Böhle A; Feller AC
    Int J Oncol; 2003 Jul; 23(1):41-8. PubMed ID: 12792774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
    Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
    Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer.
    Simon R; Bürger H; Brinkschmidt C; Böcker W; Hertle L; Terpe HJ
    J Pathol; 1998 Aug; 185(4):345-51. PubMed ID: 9828832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome 9 aberrations by fluorescence in situ hybridisation in bladder transitional cell carcinoma.
    Eleuteri P; Grollino MG; Pomponi D; De Vita R
    Eur J Cancer; 2001 Aug; 37(12):1496-503. PubMed ID: 11506956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polysomies but not Y chromosome losses have prognostic significance in pTa/pT1 urinary bladder cancer.
    Neuhaus M; Wagner U; Schmid U; Ackermann D; Zellweger T; Maurer R; Alund G; Knönagel H; Rist M; Moch H; Mihatsch MJ; Gasser TC; Sauter G
    Hum Pathol; 1999 Jan; 30(1):81-6. PubMed ID: 9923932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between genetic polymorphism of NAT2 and susceptibility to urinary bladder cancer].
    Hao GY; Zhang WD; Chen YH; Zhang DX; Zhang YH
    Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):283-6. PubMed ID: 15312364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Numerical aberrations of chromosome 8 and allelic loss at 8p in non-muscle-invasive urothelial carcinomas of the urinary bladder.
    Erbersdobler A; Kaiser H; Friedrich MG; Henke RP
    Eur Urol; 2000 Nov; 38(5):590-6. PubMed ID: 11096241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex chromosome abnormalities in bladder cancer: Y polysomies are linked to PT1-grade III transitional cell carcinoma.
    Panani AD; Roussos C
    Anticancer Res; 2006; 26(1A):319-23. PubMed ID: 16475713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal high-polysomies predict tumour progression in T1 transitional cell carcinoma of the bladder.
    Ribal MJ; Alcaraz A; Mengual L; Carrio A; Lopez-Guillermo A; Mallofré C; Palou J; Gelabert A; Villavicencio H
    Eur Urol; 2004 May; 45(5):593-9. PubMed ID: 15082201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aneusomy of chromosomes 7 and 17 predicts the recurrence of transitional cell carcinoma of the urinary bladder.
    Watters AD; Ballantyne SA; Going JJ; Grigor KM; Bartlett JM
    BJU Int; 2000 Jan; 85(1):42-7. PubMed ID: 10619944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?
    Bartlett JM; Watters AD; Ballantyne SA; Going JJ; Grigor KM; Cooke TG
    Br J Cancer; 1998 Jun; 77(12):2193-8. PubMed ID: 9649132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer.
    Hsieh FI; Pu YS; Chern HD; Hsu LI; Chiou HY; Chen CJ
    Br J Cancer; 1999 Oct; 81(3):537-41. PubMed ID: 10507782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade.
    Mahdy E; Pan Y; Wang N; Malmström PU; Ekman P; Bergerheim U
    Anticancer Res; 2001; 21(5):3167-73. PubMed ID: 11848469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interphase cytogenetics of bladder cancer progression: relationship between aneusomy, DNA ploidy pattern, histopathology, and clinical outcome.
    Cianciulli AM; Bovani R; Leonardo F; Antenucci A; Gandolfo GM; Giannarelli D; Leonardo C; Iori F; Laurenti C
    Int J Clin Lab Res; 2000; 30(1):5-11. PubMed ID: 10984125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.